Filter posts

For Health Insurers, Business is Booming. But at Whose Expense?

Good news for the health insurance industry: business is booming – insurer stock prices soared …

ICYMI: WSJ Editors on “Biotech’s Breakthrough Year”

2017 was an amazing year for biomedical advances, with 46 novel drug approvals, a near …

Value Assessment Tools that take “Precision” out of “Precision Medicine” are Harmful to Pati...

The conversation about health care costs is front and center in Washington, and new data …

ICYMI: Major Canadian Online Pharmacy Caught Red Handed Selling Fake Drugs to the U.S.

The Wall Street Journal reports that companies controlled by the online pharmacy Canada Drugs have …

Steps to Improve Competition in the Prescription Drug Marketplace

Recently on BIOtechNOW, we shared Three Encouraging Steps on Prescription Drug Costs which looked at recent …

BIO’s Tom DiLenge Testifies on Biotechnology Innovation Ecosystem before House E&C #SubHealth

At a hearing today held by the House Energy and Commerce Subcommittee on Health on …

Celebrating 21st Century Cures One Year Later

Today marks an important day for America. It was just one year ago that the …

Five Questions for the Senate Hearing on Prescription Drugs

On Tuesday, the Senate Committee on Health, Education, Labor, and Pensions will hold its third …

New Data Reaffirms Positive Trend in Prescription Drug Spending

Earlier this year, BIO launched DrugCostFacts.org to help explain how our drug cost ecosystem works …

Biopharma Steps Up as Diabetes Epidemic Goes Global

This May, the World Health Organization (WHO) named its new Director-General Dr. Tedros Adhanom Chebreyesus, …